|
[1]
|
Desantis, C., Ma, J., Bryan, L. and Jemal, A. (2014) Breast Cancer Statistics, 2013. CA: A Cancer Journal for Clinicians, 64, 52-62.
[Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Horton, J.K., Jagsi, R., Woodward, W.A. and Ho, A. (2018) Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics, 100, 23-37.
[Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Fontes-Sousa, M., Amorim, M., Salta, S., Palma, D.S.S., Henrique, R. and Jeronimo, C. (2019) Predicting Resistance to Endocrine Therapy in Breast Cancer: It’s Time for Epigenetic Biomarkers (Review). Oncology Reports, 41, 1431-1438.
[Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Mercer, T.R., Dinger, M.E. and Mattick, J.S. (2009) Long Non-Coding RNAs: Insights into Functions. Nature Reviews Genetics, 10, 155-159.
[Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kang, M.J., Abdelmohsen, K., Hutchison, E.R., et al. (2014) HuD Regulates Coding and Noncoding RNA to Induce APP → Aβ Processing. Cell Reports, 7, 1401-1409.
[Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Mendell, J.T. (2016) Targeting a Long Noncoding RNA in Breast Cancer. The New England Journal of Medicine, 374, 2287-2289.
[Google Scholar] [CrossRef]
|
|
[7]
|
Touvier, M., Fassier, P., His, M., et al. (2015) Cholesterol and Breast Cancer Risk: A Systematic Review and Meta-Analysis of Prospective Studies. British Journal of Nutrition, 114, 347-357.
[Google Scholar] [CrossRef]
|
|
[8]
|
Kitahara, C.M., Berrington, D.G.A., Freedman, N.D., et al. (2011) Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea. Journal of Clinical Oncology, 29, 1592-1598.
[Google Scholar] [CrossRef]
|
|
[9]
|
Melvin, J.C., Seth, D., Holmberg, L., et al. (2012) Lipid Profiles and Risk of Breast and Ovarian Cancer in the Swedish AMORIS Study. Cancer Epidemiology, Biomarkers & Prevention, 21, 1381-1384.
[Google Scholar] [CrossRef]
|
|
[10]
|
Goldstein, J.L., Debose-Boyd, R.A. and Brown, M.S. (2006) Protein Sensors for Membrane Sterols. Cell, 124, 35-46.
[Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Borgquist, S., Giobbie-Hurder, A., Ahern, T.P., et al. (2017) Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. Journal of Clinical Oncology, 35, 1179-1188.
[Google Scholar] [CrossRef]
|
|
[12]
|
Horton, J.D., Shimomura, I., Brown, M.S., Hammer, R.E., Goldstein, J.L. and Shimano, H. (1998) Activation of Cholesterol Synthesis in Preference to Fatty Acid Synthesis in Liver and Adipose Tissue of Transgenic Mice Overproducing Sterol Regulatory Element-Binding Protein-2. Journal of Clinical Investigation, 101, 2331-2339.
[Google Scholar] [CrossRef]
|
|
[13]
|
Shimano, H., Shimomura, I., Hammer, R.E., et al. (1997) Elevated Levels of SREBP-2 and Cholesterol Synthesis in Livers of Mice Homozygous for a Targeted Disruption of the SREBP-1 Gene. Journal of Clinical Investigation, 100, 2115-2124.
[Google Scholar] [CrossRef]
|